- Home
- LOCO vs BNTC Comparison
LOCO vs BNTC Comparison
Compare LOCO & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOCO
- BNTC
- Stock Information
- Founded
- LOCO 1980
- BNTC 1995
- Country
- LOCO United States
- BNTC United States
- Employees
- LOCO N/A
- BNTC N/A
- Industry
- LOCO Restaurants
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- LOCO Consumer Discretionary
- BNTC Health Care
- Exchange
- LOCO Nasdaq
- BNTC Nasdaq
- Market Cap
- LOCO 327.1M
- BNTC 339.8M
- IPO Year
- LOCO 2014
- BNTC N/A
- Fundamental
- Price
- LOCO $10.08
- BNTC $14.97
- Analyst Decision
- LOCO Buy
- BNTC Strong Buy
- Analyst Count
- LOCO 3
- BNTC 7
- Target Price
- LOCO $15.50
- BNTC $24.43
- AVG Volume (30 Days)
- LOCO 311.4K
- BNTC 32.9K
- Earning Date
- LOCO 03-06-2025
- BNTC 05-12-2025
- Dividend Yield
- LOCO N/A
- BNTC N/A
- EPS Growth
- LOCO 16.22
- BNTC N/A
- EPS
- LOCO 0.86
- BNTC N/A
- Revenue
- LOCO $473,008,000.00
- BNTC N/A
- Revenue This Year
- LOCO $6.09
- BNTC N/A
- Revenue Next Year
- LOCO $1.28
- BNTC N/A
- P/E Ratio
- LOCO $11.72
- BNTC N/A
- Revenue Growth
- LOCO 0.93
- BNTC N/A
- 52 Week Low
- LOCO $8.17
- BNTC $4.75
- 52 Week High
- LOCO $14.25
- BNTC $15.29
- Technical
- Relative Strength Index (RSI)
- LOCO 30.83
- BNTC 70.53
- Support Level
- LOCO $10.25
- BNTC $11.99
- Resistance Level
- LOCO $11.08
- BNTC $13.00
- Average True Range (ATR)
- LOCO 0.50
- BNTC 1.03
- MACD
- LOCO -0.11
- BNTC 0.34
- Stochastic Oscillator
- LOCO 15.08
- BNTC 94.17
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.